Back to companies
Propanc Biopharma, Inc.
PPCBAUNASDAQPharmaceuticals & HealthcarePropanc Biopharma, Inc.
Revenue
—
FY2026
Operating income
-$18.2mn
FY2026
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API